Bristol Myers (BMY) operating income was $13.0B in FY2020 (+85% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2020
$13.0B
+85%
2019
$7.0B
+35%
2018
$5.2B
+50%
2017
$3.5B
-23%
2016
$4.5B
+138%
2015
$1.9B
-27%
2014
$2.6B
-16%
2013
$3.1B
-37%
2012
$4.9B
-36%
2011
$7.6B
+9%
2010
$7.0B
+14%
2009
$6.1B
Recent Quarterly Operating Income
Quarter
Operating Income
Q2 2026
$4.5B
Q1 2026
$3.8B
Q4 2025
$3.6B
Q3 2025
$4.5B
Q2 2025
$4.6B
Q1 2025
$4.3B
Q4 2024
$2.2B
Q3 2024
$4.6B
Q2 2024
$4.1B
Q1 2024
$3.9B
Q4 2023
$4.2B
Q3 2023
$4.2B
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.